SANOFI PASTEUR
Patent Owner
Stats
- 13 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Mar 01, 2018 most recent publication
Details
- 13 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 365 Total Citation Count
- May 14, 1998 Earliest Filing
- 16 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2015/0265,695 VACCINE COMPOSITIONS FOR PREVENTION AGAINST DENGUE VIRUS INFECTIONJul 24, 13Sep 24, 15[A61K, C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9358294 Method for formulating a vaccine containing at least two antigens capable of adsorbing onto aluminium oxyhydroxideJan 17, 13Jun 07, 16[A61K, C12N]
9145445 Methods for purifying pertussis toxin and peptides useful thereforJul 30, 12Sep 29, 15[C07K]
9019496 Method for estimating the amount of entities deposited on microparticles in suspension in a solution, associated device and use of said deviceJul 22, 11Apr 28, 15[G01N]
8142795 Stabilizer and vaccine composition comprising one or more live attenuated flavivirusesJul 09, 09Mar 27, 12[A61K, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0273,035 VACCINATION AGAINST JAPANESE ENCEPHALITIS, MEASLES, MUMPS AND RUBELLAAbandonedOct 03, 13Oct 01, 15[A61K, C12N]
2013/0028,934 Stabilizer and Vaccine Composition Comprising One or More Live Attenuated FlavivirusesAbandonedMar 26, 12Jan 31, 13[A61K, A61P]
2012/0156,281 Meningococcal Vaccine Based on Lipooligosaccharide (LOS) and Neisseria Meningitidis ProteinAbandonedMay 12, 10Jun 21, 12[A61K, A61P]
2012/0003,238 Enterovirus Vaccines for Preventing or Treating Type 1 Diabetes (I)AbandonedJun 30, 11Jan 05, 12[A61K, A61P]
2012/0003,239 Enterovirus Vaccines for Preventing and Treating Type 1 Diabetes (II)AbandonedJun 30, 11Jan 05, 12[A61K, C12Q, A61P]
2012/0003,240 Enterovirus Vaccines for Preventing or Treating Type 1 Diabetes (III)AbandonedJun 30, 11Jan 05, 12[A61K, A61P]
2010/0291,192 Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteriaAbandonedMay 14, 10Nov 18, 10[A61K, A61P]
2010/0247,557 Immunostimulant Composition Comprising At Least One Toll-Like Receptor 7 Or Toll-Like Receptor 8 Agonist And A Toll-Like Receptor 4 AgonistAbandonedJun 09, 10Sep 30, 10[A61K]
2010/0111,990 Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected WomenAbandonedMar 17, 08May 06, 10[A61K, C07H, C12N, A61P, C07K]
2008/0107,685 Live Attenuated Dengue 3 Virus StrainsAbandonedJun 01, 07May 08, 08[A61K, C07H, C12N, C07K]
2007/0087,009 Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonistAbandonedDec 20, 04Apr 19, 07[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.